Next Article in Journal
Redifferentiation of Articular Chondrocytes by Hyperacute Serum and Platelet Rich Plasma in Collagen Type I Hydrogels
Next Article in Special Issue
Bactericidal and Cytotoxic Properties of Silver Nanoparticles
Previous Article in Journal
Presence of Round Cells Proteins do not Interfere with Identification of Human Sperm Proteins from Frozen Semen Samples by LC-MS/MS
Previous Article in Special Issue
Studies on Silver Ions Releasing Processes and Mechanical Properties of Surface-Modified Titanium Alloy Implants
Article

Functionalized β-Cyclodextrin Immobilized on Ag-Embedded Silica Nanoparticles as a Drug Carrier

1
Department of Bioscience and Biotechnology, Konkuk University, Seoul 05029, Korea
2
Bio-Health Convergence Institute, Korea Testing Certification, Gunpo 15809, Korea
*
Author to whom correspondence should be addressed.
Int. J. Mol. Sci. 2019, 20(2), 315; https://doi.org/10.3390/ijms20020315
Received: 18 December 2018 / Revised: 8 January 2019 / Accepted: 12 January 2019 / Published: 14 January 2019
(This article belongs to the Special Issue Silver Nano/microparticles: Modification and Applications)
Cyclodextrins (CDs) have beneficial characteristics for drug delivery, including hydrophobic interior surfaces. Nanocarriers with β-CD ligands have been prepared with simple surface modifications as drug delivery vehicles. In this study, we synthesized β-CD derivatives on an Ag-embedded silica nanoparticle (NP) (SiO2@Ag NP) structure to load and release doxorubicin (DOX). Cysteinyl-β-CD and ethylenediamine-β-CD (EDA-β-CD) were immobilized on the surface of SiO2@Ag NPs, as confirmed by transmission electron microscopy (TEM), ultraviolet-visible (UV-Vis) spectrophotometry, and Fourier transform infrared (FTIR) spectroscopy. DOX was introduced into the β-CD on the SiO2@Ag NPs and then successfully released. Neither cysteinyl-β-CD and EDA-β-CD showed cytotoxicity, while DOX-loaded cysteinyl-β-CD and EDA-β-CD showed a significant decrease in cell viability in cancer cells. The SiO2@Ag NPs with β-CD provide a strategy for designing a nanocarrier that can deliver a drug with controlled release from modified chemical types. View Full-Text
Keywords: cyclodextrin; doxorubicin (DOX); drug delivery cyclodextrin; doxorubicin (DOX); drug delivery
Show Figures

Figure 1

MDPI and ACS Style

Kang, E.J.; Baek, Y.M.; Hahm, E.; Lee, S.H.; Pham, X.-H.; Noh, M.S.; Kim, D.-E.; Jun, B.-H. Functionalized β-Cyclodextrin Immobilized on Ag-Embedded Silica Nanoparticles as a Drug Carrier. Int. J. Mol. Sci. 2019, 20, 315. https://doi.org/10.3390/ijms20020315

AMA Style

Kang EJ, Baek YM, Hahm E, Lee SH, Pham X-H, Noh MS, Kim D-E, Jun B-H. Functionalized β-Cyclodextrin Immobilized on Ag-Embedded Silica Nanoparticles as a Drug Carrier. International Journal of Molecular Sciences. 2019; 20(2):315. https://doi.org/10.3390/ijms20020315

Chicago/Turabian Style

Kang, Eun J., Yu M. Baek, Eunil Hahm, Sang H. Lee, Xuan-Hung Pham, Mi S. Noh, Dong-Eun Kim, and Bong-Hyun Jun. 2019. "Functionalized β-Cyclodextrin Immobilized on Ag-Embedded Silica Nanoparticles as a Drug Carrier" International Journal of Molecular Sciences 20, no. 2: 315. https://doi.org/10.3390/ijms20020315

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop